Characterization of five evolutionary conserved regions of the human tyrosine hydroxylase (TH) promoter: Implications for the engineering of a human TH minimal promoter assembled in a self-inactivating lentiviral vector system

Journal of Cellular Physiology

Volumn 204, Issue 2, 2005, Pages 666-677

  Romano, Gaetano ^a   Suon, Sokreine ^a   Jin, Hao ^a   Donaldson, Angela E ^a   Iacovitti, Lorraine ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TRANSPLANTATION; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; DRUG MIXTURE; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE TRANSFER; GENETIC CONSERVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; BIOMEDICAL ENGINEERING; CELLS, CULTURED; CONSERVED SEQUENCE; CORPUS STRIATUM; EVOLUTION, MOLECULAR; GENE EXPRESSION PROFILING; GENETIC VECTORS; HUMANS; LENTIVIRUS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RATS; SUBSTANTIA NIGRA; SUBSTRATE SPECIFICITY; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS;

EID: 21644457732     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20319     Document Type: Article

References (40)

1. Albanese V, Faucon Biguet N, Kiefer H, Bayard E, Mallet J, Meloni R. 2001. Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet 10:1785-1792.
2. Baffi JS, Palkovits M, Castillo SO, Mezey E, Nikodem VM. 1999. Differential expression of tyrosine hydroxylase in catecholaminergic neurons of neonatal wild-type and nurrl-deficient mice. Neuroscience 93:631-642.
3. Boulikas T. 1995. Chromatin domains and prediction of MAR sequences. Int Rev Cytol 162A:279-388.
4. Castillo SO, Baffi JS, Palkovits M, Goldstein DS, Kopin IJ, Witta J, Magnuson MA, Nikodem VM. 1998. Dopamine biosynthesis is selectively abolished in Substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci 11:36-46.
5. Cazorla P, Smidt MP, O'Malley KL, Burbach JPH. 2002. A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter. J Neurochem 74:1829-1837.
6. Cockerill PN, Garrard WT. 1986. Chromosomal loop anchorage sites appear to be evolutionary conserved. FEBS Lett 204:5-7.
7. Dewey RA, Morrisey G, Cowsill CM, Stone D, Bolognani F, Dodd NJ, Southgate TD, Klatzmann D, Lassmann H, Castro MG, Lowenstein PR. 1999. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma cells treated by adenovirus-mediated gene therapy: Implications for clinical trials. Nat Med 5:1256-1263.
8. Du X, Iacovitti L. 1997. Protein kinase C activators work in synergy with specific growth factors to initiate tyrosine hydroxylase expression in striatal neurons in culture. J Neurochem 68:564-569.
9. Forrester WC, van Genderen C, Jenuwein T, Grosschedl R. 1994. Dependence of enhancer-mediated transcription of the immunoglobulin μ gene on nuclear matrix attachment regions. Science 265:1221-1225.
10. Gandelman KY, Coker GT, Moffat M, O'Malley KL. 1990. Species and regional differences in the expression of cell-type specific elements at the human and rat tyrosine hydroxylase gene loci. J Neurochem 55:2149-2152.
11. Hynes M, Ye W, Wang K, Stone D, Murone M, Sauvage F, Rosenthal A. 2000. The seven-transmembrane receptor smoothened cell-autonomously induces multiple ventral cell types. Nat Neurosci 3:41-46.
12. Iwawaki T, Kohno K, Kobayashi K. 2000. Identification of a potential Nurr1 response element that activates the tyrosine hydroxylase gene reporter in cultured cells. Biochem Bioph Res Commun 274:590-595.
13. Kessler MA, Yang M, Gollomp KL, Jin H, Iacovitti L. 2003. The human tyrosine hydroxylase gene promoter. Brian Res Mol Brain Res 112:8-23.
14. Kielian T, Hickey WF. 1999. Inflammatory thoughts about glioma gene therapy. Nat Med 5:1237-1238.
15. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R. 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56.
16. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ, Lim JK, Anderson T, Isacson O. 2003a. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 85:622-634.
17. Kim TE, Park MJ, Choi EJ, Lee HS, Lee SH, Yoon SH, Oh CK, Lee BJ, Kim SU, Lee YS, Lee MA. 2003b. Cloning and cell type-specific regulation of the human tyrosine hydroxylase gene promoter. Biochem Biophys Res Commun 312: 1123-1131.
18. Lenartowski R, Goc A. 2002. Tissue-specific association of the human tyrosine hydroxylase gene with nuclear matrix. Neurosci Lett 330:151-154.
19. Lenartowski R, Grzybowski T, Miscicka-Sliwka D, Wojciechowski W, Goc A. 2003. The bovine tyrosine hydroxylase gene associates in vitro with the nuclear matrix by its first intron sequence. Acta Biochim Pol 50:865-873.
20. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872.
21. Meloni R, Albanese V, Ravassard P, Treilhou F, Mallet J. 1998. A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet 7:423-428.
22. Nagatsu T, Levitt M, Uderfriend S. 1964. Tyrosine hydroxylase, the initial step in norepinephrine biosynthesis. J Biol Chem 239:2910-2917.
23. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
24. Pear WS, Nolan GP, Scott ML, Baltimore D. 1993. Production of high-titer helper-free retrovirus by transient transfections. Proc Natl Acad Sci USA 90: 8392-8396.
25. Reed KC, Matthaei KI. 1990. Rapid preparation of DNA dot blots from tissue samples, using hot alkaline lysis and filtration onto charge-modified nylon membrane. Nucleic Acids Res 18:3093.
26. Robert JJ, Geoffroy MC, Finiels F, Mallet J. 1997. An adenoviral vector-based system to study neuronal gene expression: Analysis of the rat tyrosine hydroxylase promoter in cultured neurons. J Neurochem 68:2152-2160.
27. Romano G. 2003. Gene transfer in experimental medicine. Drug News Perspect 16:267-276.
28. Romano G, Micheli P, Pacilio C, Giordano A. 2000. Latest developments in gene transfer technology: Achievements, perspectives, and controversies over therapeutic applications. Stem Cells 18:19-39.
29. Romano G, Claudio PP, Tonini T, Giordano A. 2003. Human immunodeficiency virus type 1 (HIV-1) derived vectors: Safety considerations and controversy over therapeutic applications. Eur J Dermatol 13:424-429.
30. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM. 1998. Nurr1 is essential for the induction of the dopaminergic phenotype and survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 95:4013-4018.
31. Soneoka Y, Cannon P, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23:628-633.
32. Song S, Wang Y, Bak SY, Lang P, Ullrey D, Neve RL, O'Malley KL, Geller AI. 1997. An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem 68:1792-1803.
33. Stull N, Jung JW, Iacovitti L. 2001. Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. Brain Res Dev Brain Res 130:91-98.
34. Van Wijnen AJ, Bidwell JP, Fey EG, Penman S, Lian JB, Stein JL, Stein G. 1993. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry 32:8397-8402.
35. Wang Y, Yu L, Geller AI. 1999. Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virus-free herpes simplex virus type 1 vector system. Hum Gene Ther 10:1763-1771.
36. Wang X, Kong L, Zhang GR, Sun M, Geller AI. 2004. A preproenkephalin- neurofilament chimer promoter in a helper virus-free herpes simplex vector enhances long-term expression in the rat striatum. Neurol Dis 16: 596-603.
37. Yang M, Donaldson AE, Marshall CE, Shen J, Iacovitti L. 2004. Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo. Cell Transplant 13:535-547.
38. Yoshizaki T, Inaji M, Kouike H, Shimazaki T, Sawamoto K, Ando K, Date I, Kobayashi K, Suhara T, Uchiyama Y, Okano H. 2004. Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett 363:33-37.
39. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. 1997. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248-250.
40. Zigmond RE, Schwarzschild MA, Rittenhouse AR. 1989. Acute regulation of tyrosine hydroxylase by nerve activity and by nerve activity and by neurotransmitters via phosphorylation. Annu Rev Neurosci 12:415-461.